Patents/Assignees

Abbvie Inc.

60 patents in portfolio

US12091415utility2024
Processes for the Preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and Solid State Forms Thereof
0 cites
US12077545utility2024
Processes for the Preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and Solid State Forms Thereof
0 cites
USD1034191design2024
Container Cap
0 cites
US11993605utility2024
Processes for the Preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and Solid State Forms Thereof
0 cites
US11993606utility2024
Processes for the Preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and Solid State Forms Thereof
0 cites
US11993613utility2024
Thiazolo[5,4-b]pyridine MALT-1 Inhibitors
0 cites
US11976077utility2024
Processes for the Preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and Solid State Forms Therof
0 cites
US11964990utility2024
1,3,4,7-tetrahydro-2h-pyrrolo[3′,2′:5,6]pyrido[2,3-b][1,4]oxazepine Bcl-2 Inhibitors
0 cites
US11939320utility2024
Modulators of the Integrated Stress Pathway
0 cites
US11897672utility2024
Sleeve Containers for Packaging Medicinal Products
0 cites
USD1007142design2023
Carrying Pack
0 cites
US11802149utility2023
Anti-amyloid Beta Antibodies and Methods of Using the Same
0 cites
US11795175utility2023
Processes for the Preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and Solid State Forms Thereof
0 cites
US11786519utility2023
Apoptosis-inducing Agents for the Treatment of Cancer and Immune and Autoimmune Diseases
0 cites
US11787815utility2023
Processes for the Preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and Solid State Forms Thereof
0 cites
US11780848utility2023
Processes for the Preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1- Carboxamide and Solid State Forms Thereof
0 cites
US11780847utility2023
Processes for the Preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1- Carboxamide and Solid State Forms Thereof
0 cites
US11773105utility2023
Processes for the Preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]- Pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and Solid State Forms Thereof
0 cites
US11773106utility2023
Processes for the Preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and Solid State Forms Thereof
0 cites
US11767310utility2023
Nicotinamide RIPK1 Inhibitors
0 cites

← PreviousPage 2 of 3Next →